MEI Pharma Inc.

11/30/2021 | Press release | Distributed by Public on 11/30/2021 06:05

MEI Pharma and Kyowa Kirin Announce Data From the Ongoing Global Phase 2 TIDAL Study Evaluating Zandelisib as a Single Agent in Patients with Relapsed or Refractory Follicular[...]